The drug clinical trial organization of PKUPH is responsible for management of drug clinical trials of the whole hospital. The drug clinical trial organization of PKUHP has been carrying out drug clinical trials since 1980s and is a clinical pharmacology base among the first batches approved by the Ministry of Health. In 2007, it passed the examination and was granted the drug clinical trial organization qualification certificate issued by State Food and Drug Administration. In 2011 and 2015, it passed the review examination of the drug clinical trial organization qualification certificate. Now 17 specialties of the hospital have been qualified by State Food and Drug Administration. The drug clinical trial organization of PKUPH is able to carry out phase I-IV drug clinical trials and may also undertake clinical trials of medical devices and in vitro diagnostic reagents. In recent years, the organization has undertaken multiple international multi-center trials. PKUPH has won financial support from two special programs for construction of the drug clinical trial organization:
1) National Major Special Science & Technology Program of the "Twelfth Five-year Plan" Period—construction of the international platform for clinical evaluation and research of new drugs against major diseases such as autoimmune diseases and viral hepatitis;
2) Beijing Science & Technology Commission—Beijing International Platform for Clinical Research and Development of Drugs. The drug clinical trial organization of PKUPH is constantly upgrading research conditions, enhancing training of relevant clinical personnel and improving the research ability and clinical trial levels and has made tremendous contributions to the drug clinical trial of China.